There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Affordable Prescriptions for Patients Through Promoting Competition Act of 2019

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Federal Trade Commission Act to prohibit anticompetitive behaviors by drug product manufacturers, and for other purposes.


Actions Overview (1)

Date Actions Overview
11/18/2019Introduced in House

All Actions (6)

Date All Actions
11/21/2019Ordered to be Reported.
Action By: Committee on the Judiciary
11/21/2019Committee Consideration and Mark-up Session Held.
Action By: Committee on the Judiciary
11/19/2019Subcommittee on Antitrust, Commercial, and Administrative Law Discharged.
11/18/2019Referred to the House Committee on the Judiciary.
Action By: House of Representatives
11/18/2019Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Action By: Committee on the Judiciary
11/18/2019Introduced in House
Action By: House of Representatives

Cosponsors (5)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Collins, Doug [R-GA-9]* 11/18/2019
Rep. Nadler, Jerrold [D-NY-10]* 11/18/2019
Rep. Sensenbrenner, F. James, Jr. [R-WI-5]* 11/18/2019
Rep. McBath, Lucy [D-GA-6] 11/20/2019
Rep. Cline, Ben [R-VA-6] 11/20/2019

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Judiciary11/18/2019 Referred to
11/21/2019 Markup by
House Judiciary Subcommittee on Antitrust, Commercial, and Administrative Law11/18/2019 Referred to
11/19/2019 Discharged from

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (1)


Latest Summary (0)

A summary is in progress.